(2-Isopropyl-4-methoxyphenyl)methanol, 95%, 250mg

4-(2,5-dimethyl-3-thienyl)-2-hydrazinopyrimidine, 95.0%, 1g

6-Chloro-pyrimidin-4-ylamine, 98.0%, 25g

9-Methyl-3-methylene-2,3-dihydro-1H-carbazol-4(9H)-one, 97%, 25g

Ethyl 4-(chlorosulfonyl)benzoate, 95.0%, 5g

5-[4-(methylthio)phenyl]-1,3,4-oxadiazol-2-amine, 95.0%, 500mg

(6-METHOXY-PYRIDIN-2-YL)-ACETIC ACID, 95.0%, 10g

(R)-2-(4-CHLOROPHENYL)PYRROLIDINE, 95.0%, 250mg

Ethyl 2-cyclopropyl-6-oxo-1,6-dihydropyrimidine-5-carboxylate, 97.0%, 250mg

Récipient de réaction à bride plate, cylindrique, gradué, avec enveloppe de trempe et de vide et vanne de vidange, DN 100, 4000 ml, 250 mm, 1 pièce

(�)-trans-4-Isopropylpyrrolidine-3-carboxylic acid hydrochloride, 97.0%, 1g

(S)-2-Methyl-3-phenylpropanoic acid, 100mg

Hexahydroxoantimonate(V) de potassium, 98 % min., 500 g, emballage plastique.